Moderna, the biotechnology company behind a key COVID-19 vaccine, says it will build a new facility in Africa, aimed at producing up to 500 million doses of vaccines a year.
Enter Your Information Below To Receive Latest News About Stock Market.
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!